Breast Cancer Drug Analysis Flags Dementia Signals for Anastrozole in Women Over 50
A large pharmacovigilance analysis of FDA adverse event reports found no overall dementia risk signal for endocrine and targeted breast ...
A large pharmacovigilance analysis of FDA adverse event reports found no overall dementia risk signal for endocrine and targeted breast ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine